Advertisement
Singapore markets closed
  • Straits Times Index

    3,415.51
    +47.61 (+1.41%)
     
  • S&P 500

    5,509.01
    +33.92 (+0.62%)
     
  • Dow

    39,331.85
    +162.33 (+0.41%)
     
  • Nasdaq

    18,028.76
    +149.46 (+0.84%)
     
  • Bitcoin USD

    60,208.45
    -2,501.72 (-3.99%)
     
  • CMC Crypto 200

    1,296.96
    -37.96 (-2.84%)
     
  • FTSE 100

    8,168.10
    +46.90 (+0.58%)
     
  • Gold

    2,355.00
    +21.60 (+0.93%)
     
  • Crude Oil

    82.88
    +0.07 (+0.08%)
     
  • 10-Yr Bond

    4.4360
    -0.0430 (-0.96%)
     
  • Nikkei

    40,580.76
    +506.07 (+1.26%)
     
  • Hang Seng

    17,978.57
    +209.43 (+1.18%)
     
  • FTSE Bursa Malaysia

    1,615.32
    +17.36 (+1.09%)
     
  • Jakarta Composite Index

    7,196.75
    +71.61 (+1.01%)
     
  • PSE Index

    6,450.03
    +91.07 (+1.43%)
     

E.W. Scripps (NASDAQ:SSP) shareholders have endured a 51% loss from investing in the stock five years ago

While not a mind-blowing move, it is good to see that the The E.W. Scripps Company (NASDAQ:SSP) share price has gained 21% in the last three months. But that doesn't change the fact that the returns over the last half decade have been disappointing. Indeed, the share price is down 53% in the period. So is the recent increase sufficient to restore confidence in the stock? Not yet. Of course, this could be the start of a turnaround.

It's worthwhile assessing if the company's economics have been moving in lockstep with these underwhelming shareholder returns, or if there is some disparity between the two. So let's do just that.

Check out our latest analysis for E.W. Scripps

While the efficient markets hypothesis continues to be taught by some, it has been proven that markets are over-reactive dynamic systems, and investors are not always rational. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

ADVERTISEMENT

In the last half decade E.W. Scripps saw its share price fall as its EPS declined below zero. This was, in part, due to extraordinary items impacting earnings. At present it's hard to make valid comparisons between EPS and the share price. However, we can say we'd expect to see a falling share price in this scenario.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
earnings-per-share-growth

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

A Different Perspective

Investors in E.W. Scripps had a tough year, with a total loss of 49%, against a market gain of about 16%. However, keep in mind that even the best stocks will sometimes underperform the market over a twelve month period. Unfortunately, last year's performance may indicate unresolved challenges, given that it was worse than the annualised loss of 9% over the last half decade. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with E.W. Scripps (at least 1 which makes us a bit uncomfortable) , and understanding them should be part of your investment process.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.